Pharmaceuticals, Biotechnology and Life Sciences
PARIS–(BUSINESS WIRE)–#IL2mutein–Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company developing precision medicines that modulate regulatory T cells (Tregs) to restore…
– Study data suggests IGV-001 provides patients with a clinically meaningful improvement in overall survival (+6.3 months; +45%) compared to…
Comprehensive Analyses Across Interventional and Observational Trials Show that Hippocampal Atrophy Closely Tracks with Memory Loss and Disease Progression, and…
Ideagen’s CEO explains why binary outcomes and high stakes make compliance ideal for autonomous AI NOTTINGHAM, England–(BUSINESS WIRE)–#AEC–The CEO of…
CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies,…
Reaffirms fiscal 2026 revenue guidance of $79 to $82 million and adjusted diluted EPS guidance of $1.03 to $1.10 Investor…
Phase 1 data demonstrates durable responses and rPFS coupled with a manageable safety profile rPFS of 7.9-8.9 months in heavily…
DUBLIN–(BUSINESS WIRE)–The “Human Vaccines – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for…
SOBIN-AD Also Reduces Aβ Plaque Formation and Synaptophysin Loss in Asymptomatic Disease in a Preclinical Model SEATTLE–(BUSINESS WIRE)–#Alzheimers–AltPep Corporation, a…
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of…